|1.||Chung, Ill-Min: 3 articles (04/2014 - 01/2008)|
|2.||Choi, Yung Hyun: 1 article (04/2014)|
|3.||Park, Cheol: 1 article (04/2014)|
|4.||Yoo, Young Hyun: 1 article (04/2014)|
|5.||Jeong, Na Young: 1 article (04/2014)|
|6.||Han, Min Ho: 1 article (04/2014)|
|7.||Kim, Wun-Jae: 1 article (04/2014)|
|8.||Kim, Gi-Young: 1 article (04/2014)|
|9.||Yang, Young Mok: 1 article (09/2008)|
|10.||Yoon, So-Young: 1 article (09/2008)|
04/01/2014 - "The present study was conducted using cultured human leukemia U937 cells to elucidate the possible mechanisms by which momilactone B exerts its anticancer activity, which to date has remained poorly understood. "
04/01/2014 - "Momilactone B induces apoptosis and G1 arrest of the cell cycle in human monocytic leukemia U937 cells through downregulation of pRB phosphorylation and induction of the cyclin-dependent kinase inhibitor p21Waf1/Cip1."
|2.||Breast Neoplasms (Breast Cancer)
09/01/2008 - "The purpose of the present study was to investigate the molecular mechanism by which momilactone B exerts its inhibitory effects on breast cancer cells. "
09/01/2008 - "The effects of momilactone B on cell growth and apoptosis-related gene expression were investigated in breast cancer cells under hypoxic conditions (2% O2). "
09/01/2008 - "We suggest that momilactone B accelerates hypoxia-induced apoptosis of human breast cancer cells through STAT5b, and may represent an effective chemopreventive or therapeutic agent against breast cancer."
09/01/2008 - "Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B."
09/01/2008 - "These results indicate that momilactone B inhibits the growth of breast cancer cells, regulates the expression of apoptosis-related genes, and induces apoptosis through STAT5b and a caspase-3 dependent pathway. "
|5.||Colonic Neoplasms (Colon Cancer)
03/07/2007 - "The results indicated that momilactone B from rice hulls might be a new candidate for chemotherapeutic agent against human colon cancer."
03/07/2007 - "The cytotoxic activity of momilactone B was evaluated by the MTT-dye reduction, lactate dehydrogenase (LDH), and colony-forming ability assays in human colon cancer HT-29 and SW620 cells. "
|1.||Caspase 3 (Caspase-3)
|2.||Cyclin-Dependent Kinase 4
|6.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)